Case number 2022-2174
Liquidia Technologies, Inc. v. United Therapeutics Corporation > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 18, 2022 | 4 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [883662-2] filed by Cross-Appellant Liquidia Technologies, Inc. in 22-2133; Appeal No. 22-2174 is dismissed; Each party shall bear its own costs with respect to Appeal No. 22-2174; Appeal No. 22-2174 is deconsolidated from 22-2133, and the revised official caption is reflected in the order; issuing mandate in 22-2174 only. Service as of this date by the Clerk of Court. [885200] [22-2133, 22-2174] [ALK] [Entered: 11/18/2022 04:39 PM] (2) |
| Oct 3, 2022 | 3 | Certified list received. Service: 09/27/2022 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [875472] [22-2133, 22-2174] [ALK] [Entered: 10/03/2022 04:42 PM] (84) |
| Sep 1, 2022 | 1 | Appeal docketed. Received: 08/29/2022. [869407] Entry of Appearance is due on 09/15/2022. Certificate of Interest is due on 09/15/2022. Docketing Statement is due on 09/15/2022. Certified List is due on 10/11/2022. [ALK] [Entered: 09/01/2022 09:34 AM] (0) |
| Sep 1, 2022 | 2 | Note to File: The following cases are associated: 22-2133 (Lead) with 22-2174 (Cross-Appeal). The parties must file all documents in the lead appeal only. [869410] [22-2133, 22-2174] [ALK] [Entered: 09/01/2022 09:38 AM] (0) |
